Tessera Therapeutics
Jacob Claridge has an extensive work experience in the biotechnology and pharmaceutical industry. Jacob is currently working as the Director of Technical Operations at Tessera Therapeutics. Prior to this, they had various roles at Astellas Gene Therapies, including Associate Director of Process Engineering, Senior Manager of Process Engineering, Manager of Process Engineering, and Senior Process Engineer. Jacob also worked at Moderna as a Principal Research Associate in Process Development and at Momenta Pharmaceuticals as a Research Associate in Biologics Discovery. Jacob began their career at Regeneron Pharmaceuticals as a Biotech Production Specialist.
Jacob Claridge holds a B.S. degree in Bioengineering with a minor in Business from Lehigh University. Jacob also obtained a Master of Business Administration (MBA) degree from the Haas School of Business at the University of California, Berkeley.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.